Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Vaccines made from tumor tissue may make the body build an immune response and
kill tumor cells.
PURPOSE: Phase II trial to study the effectiveness of vaccine therapy in treating patients
who have stage III or stage IV ovarian epithelial cancer.